These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10403485)

  • 1. CD28-mediated regulation of the c-jun promoter involves the MEF2 transcription factor in Jurkat T cells.
    Shin HM; Han TH
    Mol Immunol; 1999 Feb; 36(3):197-203. PubMed ID: 10403485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling from G protein-coupled receptors to the c-jun promoter involves the MEF2 transcription factor. Evidence for a novel c-jun amino-terminal kinase-independent pathway.
    Coso OA; Montaner S; Fromm C; Lacal JC; Prywes R; Teramoto H; Gutkind JS
    J Biol Chem; 1997 Aug; 272(33):20691-7. PubMed ID: 9252389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2.
    Lindgren H; Axcrona K; Leanderson T
    J Immunol; 2001 Apr; 166(7):4578-85. PubMed ID: 11254715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory role of MEF2D in serum induction of the c-jun promoter.
    Han TH; Prywes R
    Mol Cell Biol; 1995 Jun; 15(6):2907-15. PubMed ID: 7760790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vav synergizes with protein kinase C theta to mediate IL-4 gene expression in response to CD28 costimulation in T cells.
    Hehner SP; Li-Weber M; Giaisi M; Dröge W; Krammer PH; Schmitz ML
    J Immunol; 2000 Apr; 164(7):3829-36. PubMed ID: 10725744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD28 signaling augments Elk-1-dependent transcription at the c-fos gene during antigen stimulation.
    Li W; Whaley CD; Bonnevier JL; Mondino A; Martin ME; Aagaard-Tillery KM; Mueller DL
    J Immunol; 2001 Jul; 167(2):827-35. PubMed ID: 11441089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter.
    González E; Punzón C; González M; Fresno M
    J Immunol; 2001 Apr; 166(7):4560-9. PubMed ID: 11254713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The physical association of protein kinase C theta with a lipid raft-associated inhibitor of kappa B factor kinase (IKK) complex plays a role in the activation of the NF-kappa B cascade by TCR and CD28.
    Khoshnan A; Bae D; Tindell CA; Nel AE
    J Immunol; 2000 Dec; 165(12):6933-40. PubMed ID: 11120819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocyte enhancer factor 2 mediates calcium-dependent transcription of the interleukin-2 gene in T lymphocytes: a calcium signaling module that is distinct from but collaborates with the nuclear factor of activated T cells (NFAT).
    Pan F; Ye Z; Cheng L; Liu JO
    J Biol Chem; 2004 Apr; 279(15):14477-80. PubMed ID: 14722108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor of activated T cells contributes to the function of the CD28 response region of the granulocyte macrophage-colony stimulating factor promoter.
    Shang C; Attema J; Cakouros D; Cockerill PN; Shannon MF
    Int Immunol; 1999 Dec; 11(12):1945-56. PubMed ID: 10590260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a CD28 response element in the CD40 ligand promoter.
    Parra E; Mustelin T; Dohlsten M; Mercola D
    J Immunol; 2001 Feb; 166(4):2437-43. PubMed ID: 11160303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of activator protein (AP)-1 and nuclear factor-kappaB by CD28 stimulation involves both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals.
    Edmead CE; Patel YI; Wilson A; Boulougouris G; Hall ND; Ward SG; Sansom DM
    J Immunol; 1996 Oct; 157(8):3290-7. PubMed ID: 8871623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS).
    Harada Y; Ohgai D; Watanabe R; Okano K; Koiwai O; Tanabe K; Toma H; Altman A; Abe R
    J Exp Med; 2003 Jan; 197(2):257-62. PubMed ID: 12538664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Load-induced transcriptional activation of c-jun in rat myocardium: regulation by myocyte enhancer factor 2.
    Nadruz W; Kobarg CB; Constancio SS; Corat PD; Franchini KG
    Circ Res; 2003 Feb; 92(2):243-51. PubMed ID: 12574153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of CD28 expression by CD28GR, a novel promoter element located in exon 1 of the CD28 gene.
    Lin CJ; Tam RC
    J Immunol; 2001 May; 166(10):6134-43. PubMed ID: 11342633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Jun kinase cascade is responsible for activating the CD28 response element of the IL-2 promoter: proof of cross-talk with the I kappa B kinase cascade.
    Kempiak SJ; Hiura TS; Nel AE
    J Immunol; 1999 Mar; 162(6):3176-87. PubMed ID: 10092768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter.
    Parra E; McGuire K; Hedlund G; Dohlsten M
    J Immunol; 1998 Jun; 160(11):5374-81. PubMed ID: 9605137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activation.
    Skapenko A; Lipsky PE; Kraetsch HG; Kalden JR; Schulze-Koops H
    J Immunol; 2001 Apr; 166(7):4283-92. PubMed ID: 11254680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublethal levels of oxidative stress stimulate transcriptional activation of c-jun and suppress IL-2 promoter activation in Jurkat T cells.
    Beiqing L; Chen M; Whisler RL
    J Immunol; 1996 Jul; 157(1):160-9. PubMed ID: 8683110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain.
    Kasler HG; Victoria J; Duramad O; Winoto A
    Mol Cell Biol; 2000 Nov; 20(22):8382-9. PubMed ID: 11046135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.